Fulminant transfusion-associated graft-versus-host disease in a premature infant

Robert S. Berger, Steven L. Dixon

Research output: Contribution to journalArticlepeer-review


A fatal case of transfusion-associated graft-versus-host disease developed in a premature infant after receiving several blood products, including nonirradiated white blood cells. Transfusion-associated graft-versus-host disease can be prevented. Irradiation of blood products is the least controversial and most effective method. Treatment was unsuccessful in most reported cases of transfusion-associated graft-versus-host disease. Therefore irradiation of blood products before transfusing to patients susceptible to transfusion-associated graft-versus-host disease is strongly recommended.

Original languageEnglish (US)
Pages (from-to)945-950
Number of pages6
JournalJournal of the American Academy of Dermatology
Issue number5
StatePublished - Jan 1 1989
Externally publishedYes

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Fulminant transfusion-associated graft-versus-host disease in a premature infant'. Together they form a unique fingerprint.

Cite this